Michael Robin Reich, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Politics | 16 | 2024 | 821 | 3.630 |
Why?
|
| National Health Programs | 9 | 2020 | 442 | 2.280 |
Why?
|
| Health Policy | 20 | 2024 | 2698 | 2.230 |
Why?
|
| Chagas Disease | 5 | 2020 | 166 | 1.860 |
Why?
|
| Health Care Reform | 11 | 2024 | 1262 | 1.820 |
Why?
|
| Policy Making | 5 | 2024 | 545 | 1.420 |
Why?
|
| Government Programs | 3 | 2022 | 278 | 1.350 |
Why?
|
| Trypanocidal Agents | 4 | 2020 | 40 | 1.330 |
Why?
|
| Developing Countries | 17 | 2018 | 2903 | 1.250 |
Why?
|
| Nitroimidazoles | 4 | 2020 | 118 | 1.240 |
Why?
|
| Tropical Medicine | 4 | 2018 | 52 | 1.100 |
Why?
|
| Public-Private Sector Partnerships | 2 | 2018 | 123 | 0.910 |
Why?
|
| Private Sector | 8 | 2018 | 396 | 0.900 |
Why?
|
| Health Services Accessibility | 14 | 2018 | 5512 | 0.860 |
Why?
|
| Health Care Sector | 4 | 2019 | 197 | 0.800 |
Why?
|
| Drugs, Essential | 3 | 2016 | 71 | 0.730 |
Why?
|
| Drug Costs | 5 | 2020 | 1196 | 0.720 |
Why?
|
| Nutrition Policy | 2 | 2014 | 467 | 0.710 |
Why?
|
| Disasters | 4 | 2015 | 523 | 0.700 |
Why?
|
| Delivery of Health Care | 7 | 2019 | 5375 | 0.660 |
Why?
|
| Japan | 10 | 2021 | 1418 | 0.650 |
Why?
|
| Mexico | 7 | 2022 | 767 | 0.630 |
Why?
|
| Economics | 1 | 2019 | 141 | 0.620 |
Why?
|
| Quality of Health Care | 3 | 2020 | 4339 | 0.600 |
Why?
|
| Public Sector | 6 | 2018 | 266 | 0.580 |
Why?
|
| International Cooperation | 9 | 2015 | 1438 | 0.580 |
Why?
|
| Infectious Disease Medicine | 1 | 2018 | 49 | 0.580 |
Why?
|
| Government | 1 | 2018 | 161 | 0.570 |
Why?
|
| Social Responsibility | 2 | 2018 | 384 | 0.530 |
Why?
|
| Health Care Rationing | 1 | 2019 | 435 | 0.520 |
Why?
|
| Accidents, Traffic | 4 | 2007 | 819 | 0.500 |
Why?
|
| Public Health Nursing | 2 | 2014 | 14 | 0.490 |
Why?
|
| Papillomavirus Vaccines | 1 | 2021 | 497 | 0.490 |
Why?
|
| Maternal Health Services | 1 | 2020 | 471 | 0.480 |
Why?
|
| Food Supply | 3 | 2014 | 544 | 0.460 |
Why?
|
| Conservation of Natural Resources | 1 | 2016 | 209 | 0.460 |
Why?
|
| Economic Competition | 2 | 2015 | 223 | 0.460 |
Why?
|
| Leadership | 3 | 2023 | 1395 | 0.440 |
Why?
|
| Health Priorities | 5 | 2013 | 380 | 0.440 |
Why?
|
| Health Expenditures | 3 | 2016 | 2395 | 0.430 |
Why?
|
| Disclosure | 2 | 2018 | 754 | 0.430 |
Why?
|
| Interinstitutional Relations | 2 | 2006 | 236 | 0.430 |
Why?
|
| Antiprotozoal Agents | 1 | 2013 | 95 | 0.420 |
Why?
|
| Prenatal Care | 1 | 2020 | 1159 | 0.410 |
Why?
|
| Public Health | 7 | 2023 | 2682 | 0.400 |
Why?
|
| Research | 6 | 2018 | 1981 | 0.400 |
Why?
|
| Policy | 1 | 2015 | 514 | 0.380 |
Why?
|
| Drug Industry | 7 | 2018 | 793 | 0.370 |
Why?
|
| Life Expectancy | 3 | 2015 | 1249 | 0.370 |
Why?
|
| Information Dissemination | 2 | 2018 | 1137 | 0.360 |
Why?
|
| Drugs, Generic | 1 | 2015 | 454 | 0.350 |
Why?
|
| Pharmaceutical Preparations | 7 | 2015 | 1088 | 0.340 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 1640 | 0.330 |
Why?
|
| Public Health Administration | 2 | 2002 | 242 | 0.310 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2185 | 0.310 |
Why?
|
| Orphan Drug Production | 1 | 2009 | 48 | 0.310 |
Why?
|
| Health Status | 2 | 2011 | 4094 | 0.300 |
Why?
|
| Malaria | 1 | 2018 | 1241 | 0.300 |
Why?
|
| Biomedical Technology | 1 | 2009 | 210 | 0.280 |
Why?
|
| Humans | 67 | 2024 | 768393 | 0.270 |
Why?
|
| Preventive Health Services | 1 | 2011 | 568 | 0.270 |
Why?
|
| World Health Organization | 5 | 2019 | 1327 | 0.270 |
Why?
|
| Congresses as Topic | 2 | 2009 | 810 | 0.260 |
Why?
|
| Counseling | 1 | 2014 | 1553 | 0.260 |
Why?
|
| Drugs, Investigational | 2 | 2020 | 213 | 0.260 |
Why?
|
| Ethics, Institutional | 2 | 2003 | 38 | 0.260 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 1447 | 0.250 |
Why?
|
| Relief Work | 2 | 1999 | 131 | 0.250 |
Why?
|
| Internationality | 2 | 2000 | 1008 | 0.230 |
Why?
|
| Nifurtimox | 2 | 2015 | 14 | 0.230 |
Why?
|
| Population Dynamics | 2 | 2011 | 314 | 0.220 |
Why?
|
| Public Health Practice | 1 | 2006 | 221 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.210 |
Why?
|
| Telemedicine | 1 | 2020 | 3107 | 0.210 |
Why?
|
| Models, Organizational | 4 | 2010 | 548 | 0.200 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 3267 | 0.200 |
Why?
|
| Republic of Korea | 2 | 2015 | 587 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2015 | 3267 | 0.200 |
Why?
|
| Ethical Analysis | 1 | 2002 | 41 | 0.200 |
Why?
|
| Program Development | 3 | 2019 | 1298 | 0.200 |
Why?
|
| Organizations | 3 | 2018 | 172 | 0.200 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 857 | 0.190 |
Why?
|
| Wounds and Injuries | 3 | 2003 | 2514 | 0.190 |
Why?
|
| Parents | 2 | 2014 | 3596 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8753 | 0.180 |
Why?
|
| Madagascar | 1 | 2020 | 111 | 0.170 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4528 | 0.170 |
Why?
|
| Program Evaluation | 4 | 2018 | 2505 | 0.170 |
Why?
|
| Cooperative Behavior | 4 | 2018 | 1515 | 0.160 |
Why?
|
| Primary Health Care | 1 | 2016 | 4748 | 0.160 |
Why?
|
| State Government | 1 | 2002 | 389 | 0.160 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2000 | 275 | 0.160 |
Why?
|
| Reproductive Rights | 1 | 2018 | 31 | 0.160 |
Why?
|
| Drug Stability | 1 | 1999 | 291 | 0.150 |
Why?
|
| Praziquantel | 1 | 1998 | 34 | 0.150 |
Why?
|
| Trypanosoma cruzi | 1 | 2020 | 204 | 0.150 |
Why?
|
| Legislation, Drug | 1 | 2000 | 216 | 0.150 |
Why?
|
| Schistosomiasis | 1 | 1998 | 65 | 0.150 |
Why?
|
| Drug and Narcotic Control | 2 | 2000 | 145 | 0.150 |
Why?
|
| Anthelmintics | 1 | 1998 | 83 | 0.140 |
Why?
|
| Culicidae | 1 | 2018 | 110 | 0.140 |
Why?
|
| Mosquito Control | 1 | 2018 | 110 | 0.140 |
Why?
|
| Public Policy | 2 | 1994 | 551 | 0.140 |
Why?
|
| Ethics, Medical | 1 | 2002 | 785 | 0.140 |
Why?
|
| Trust | 1 | 2021 | 532 | 0.130 |
Why?
|
| Birth Rate | 2 | 2015 | 168 | 0.130 |
Why?
|
| India | 2 | 2022 | 2325 | 0.130 |
Why?
|
| Drug Labeling | 1 | 1999 | 250 | 0.130 |
Why?
|
| Haemophilus Vaccines | 1 | 2016 | 71 | 0.130 |
Why?
|
| Staff Development | 1 | 2018 | 230 | 0.130 |
Why?
|
| Legislation, Pharmacy | 1 | 1995 | 3 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2010 | 9379 | 0.130 |
Why?
|
| Pregnant Women | 1 | 2020 | 577 | 0.120 |
Why?
|
| Social Security | 1 | 2015 | 101 | 0.120 |
Why?
|
| Bacterial Capsules | 1 | 2016 | 247 | 0.120 |
Why?
|
| Motor Vehicles | 3 | 2007 | 282 | 0.120 |
Why?
|
| Radiation Monitoring | 1 | 2015 | 106 | 0.120 |
Why?
|
| Latin America | 1 | 2016 | 416 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 21162 | 0.110 |
Why?
|
| Child Health Services | 1 | 1999 | 645 | 0.110 |
Why?
|
| State Medicine | 1 | 2015 | 217 | 0.110 |
Why?
|
| Tsunamis | 1 | 2014 | 61 | 0.110 |
Why?
|
| Rural Health | 1 | 2015 | 300 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 3231 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2001 | 985 | 0.110 |
Why?
|
| Immunization Programs | 1 | 2016 | 267 | 0.110 |
Why?
|
| HIV Infections | 3 | 2006 | 17575 | 0.110 |
Why?
|
| Taxes | 1 | 2015 | 220 | 0.110 |
Why?
|
| Blood Donors | 1 | 2015 | 344 | 0.110 |
Why?
|
| Administrative Personnel | 1 | 2014 | 185 | 0.100 |
Why?
|
| Urban Health | 1 | 2015 | 535 | 0.100 |
Why?
|
| Health Planning | 1 | 2014 | 232 | 0.100 |
Why?
|
| Female | 15 | 2022 | 397089 | 0.100 |
Why?
|
| Botswana | 2 | 2006 | 1058 | 0.100 |
Why?
|
| Goals | 2 | 2015 | 716 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1672 | 0.100 |
Why?
|
| Earthquakes | 1 | 2014 | 192 | 0.100 |
Why?
|
| Schools, Public Health | 1 | 1991 | 23 | 0.100 |
Why?
|
| Public Opinion | 1 | 2015 | 486 | 0.090 |
Why?
|
| Poverty | 5 | 2009 | 2721 | 0.090 |
Why?
|
| Cost Control | 1 | 2013 | 627 | 0.090 |
Why?
|
| Efficiency, Organizational | 1 | 1994 | 700 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 1669 | 0.080 |
Why?
|
| Technology, High-Cost | 1 | 2009 | 32 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2016 | 2740 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1575 | 0.080 |
Why?
|
| Pregnancy | 3 | 2020 | 30200 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2015 | 2437 | 0.080 |
Why?
|
| Government Agencies | 2 | 2008 | 161 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3431 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4571 | 0.080 |
Why?
|
| Home Childbirth | 1 | 1989 | 55 | 0.080 |
Why?
|
| Peer Group | 1 | 2014 | 698 | 0.080 |
Why?
|
| Fraud | 2 | 2002 | 66 | 0.080 |
Why?
|
| Drug Utilization | 2 | 2008 | 1191 | 0.080 |
Why?
|
| Health Literacy | 1 | 2014 | 468 | 0.080 |
Why?
|
| Parenting | 1 | 2014 | 708 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2014 | 1142 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2020 | 26411 | 0.070 |
Why?
|
| Malnutrition | 1 | 2014 | 631 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2015 | 2771 | 0.070 |
Why?
|
| Culture | 1 | 2011 | 623 | 0.070 |
Why?
|
| Insurance, Liability | 1 | 1988 | 100 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 1988 | 149 | 0.070 |
Why?
|
| Insurance, Health | 2 | 2015 | 2518 | 0.070 |
Why?
|
| Age Factors | 2 | 2020 | 18471 | 0.070 |
Why?
|
| Seat Belts | 1 | 2007 | 60 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 4047 | 0.070 |
Why?
|
| Environmental Pollution | 1 | 1988 | 125 | 0.070 |
Why?
|
| Forecasting | 1 | 2015 | 2948 | 0.070 |
Why?
|
| Developed Countries | 2 | 2007 | 452 | 0.070 |
Why?
|
| Social Class | 1 | 2015 | 2009 | 0.070 |
Why?
|
| Automobiles | 1 | 2007 | 112 | 0.070 |
Why?
|
| Foundations | 1 | 2006 | 96 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2010 | 1221 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2007 | 24318 | 0.060 |
Why?
|
| Transportation | 1 | 2007 | 217 | 0.060 |
Why?
|
| Health Resources | 1 | 1991 | 950 | 0.060 |
Why?
|
| Safety | 2 | 2007 | 1159 | 0.060 |
Why?
|
| Drug Therapy | 2 | 2000 | 504 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 3486 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7453 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2009 | 630 | 0.050 |
Why?
|
| Feminism | 1 | 2002 | 6 | 0.050 |
Why?
|
| Bangladesh | 2 | 1995 | 741 | 0.050 |
Why?
|
| Philosophy, Medical | 1 | 2002 | 78 | 0.050 |
Why?
|
| United States | 5 | 2020 | 73150 | 0.050 |
Why?
|
| International Agencies | 1 | 2002 | 245 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 1989 | 952 | 0.050 |
Why?
|
| Bicycling | 1 | 2003 | 177 | 0.050 |
Why?
|
| Probability | 1 | 2007 | 2482 | 0.050 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2046 | 0.050 |
Why?
|
| Male | 8 | 2016 | 364902 | 0.040 |
Why?
|
| Delphi Technique | 2 | 1996 | 888 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 1988 | 1490 | 0.040 |
Why?
|
| Communication | 1 | 2014 | 3912 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3413 | 0.040 |
Why?
|
| Human Rights | 1 | 2002 | 312 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26375 | 0.040 |
Why?
|
| Social Change | 1 | 1999 | 153 | 0.040 |
Why?
|
| Patents as Topic | 1 | 2000 | 111 | 0.040 |
Why?
|
| Walking | 2 | 2003 | 1201 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2002 | 540 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 1988 | 1290 | 0.040 |
Why?
|
| Social Perception | 1 | 2002 | 433 | 0.040 |
Why?
|
| Automobile Driving | 1 | 2003 | 442 | 0.040 |
Why?
|
| Curriculum | 1 | 1991 | 3776 | 0.040 |
Why?
|
| Social Work | 1 | 2018 | 157 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2002 | 555 | 0.040 |
Why?
|
| Adult | 5 | 2020 | 223640 | 0.030 |
Why?
|
| Cost of Illness | 2 | 2003 | 1959 | 0.030 |
Why?
|
| School Health Services | 1 | 2000 | 389 | 0.030 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 94 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5538 | 0.030 |
Why?
|
| Indonesia | 1 | 2016 | 131 | 0.030 |
Why?
|
| Adolescent | 4 | 2016 | 89184 | 0.030 |
Why?
|
| Socioeconomic Factors | 3 | 2008 | 7861 | 0.030 |
Why?
|
| Philippines | 1 | 1995 | 95 | 0.030 |
Why?
|
| Sri Lanka | 1 | 1995 | 93 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 945 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3579 | 0.030 |
Why?
|
| Economics, Pharmaceutical | 1 | 1995 | 88 | 0.030 |
Why?
|
| Italy | 2 | 1994 | 854 | 0.030 |
Why?
|
| Prejudice | 1 | 2018 | 574 | 0.030 |
Why?
|
| Emergency Medical Services | 2 | 2003 | 1946 | 0.030 |
Why?
|
| Systems Analysis | 1 | 2015 | 168 | 0.030 |
Why?
|
| Infant | 3 | 2014 | 36510 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2014 | 42650 | 0.030 |
Why?
|
| Financial Management | 1 | 1994 | 161 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 223491 | 0.020 |
Why?
|
| Social Stigma | 1 | 2018 | 785 | 0.020 |
Why?
|
| Health Education | 1 | 2018 | 1057 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 500 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2002 | 1428 | 0.020 |
Why?
|
| Child | 5 | 2003 | 80891 | 0.020 |
Why?
|
| Motivation | 1 | 2000 | 2029 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 59686 | 0.020 |
Why?
|
| Research Personnel | 1 | 2014 | 590 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 1996 | 900 | 0.020 |
Why?
|
| Nurse Midwives | 1 | 1989 | 24 | 0.020 |
Why?
|
| Universities | 1 | 2014 | 1005 | 0.020 |
Why?
|
| Hospitalization | 1 | 1989 | 10844 | 0.020 |
Why?
|
| Labor Unions | 1 | 1988 | 49 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 81801 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 412 | 0.020 |
Why?
|
| Fees, Pharmaceutical | 1 | 2008 | 66 | 0.020 |
Why?
|
| Workers' Compensation | 1 | 1988 | 150 | 0.020 |
Why?
|
| Self Medication | 1 | 2008 | 115 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2661 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1996 | 2202 | 0.020 |
Why?
|
| Risk Factors | 3 | 2003 | 74962 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 1988 | 252 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1082 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 9510 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 169337 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2010 | 1090 | 0.020 |
Why?
|
| Prescriptions | 1 | 2008 | 388 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 3131 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3922 | 0.010 |
Why?
|
| Community Mental Health Services | 1 | 1988 | 388 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 21544 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2000 | 3464 | 0.010 |
Why?
|
| Pediatrics | 1 | 1999 | 3624 | 0.010 |
Why?
|
| Social Support | 1 | 2014 | 2191 | 0.010 |
Why?
|
| Netherlands | 1 | 1989 | 2274 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1989 | 757 | 0.010 |
Why?
|
| Health Services Research | 1 | 1991 | 1817 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1409 | 0.010 |
Why?
|
| Motorcycles | 1 | 2003 | 42 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 171562 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3627 | 0.010 |
Why?
|
| Neoplasms | 1 | 2010 | 22385 | 0.010 |
Why?
|
| Egypt | 1 | 2000 | 100 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5792 | 0.010 |
Why?
|
| Dominican Republic | 1 | 1999 | 78 | 0.010 |
Why?
|
| Vincristine | 1 | 2002 | 1040 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2015 | 4848 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2008 | 2240 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2000 | 332 | 0.010 |
Why?
|
| Prednisone | 1 | 2002 | 1567 | 0.010 |
Why?
|
| Health Plan Implementation | 1 | 2000 | 338 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2226 | 0.010 |
Why?
|
| Child Welfare | 1 | 2000 | 523 | 0.010 |
Why?
|
| Office Visits | 1 | 2000 | 596 | 0.010 |
Why?
|
| Switzerland | 1 | 1996 | 323 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2002 | 2229 | 0.010 |
Why?
|
| Genomics | 1 | 2010 | 5916 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 9516 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3794 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 17135 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40272 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2000 | 1946 | 0.000 |
Why?
|
| Regional Health Planning | 1 | 1988 | 96 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2010 | 23631 | 0.000 |
Why?
|
| Hospitals, Psychiatric | 1 | 1988 | 318 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 15455 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 11854 | 0.000 |
Why?
|
| Health Services Needs and Demand | 1 | 1988 | 1407 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2002 | 65379 | 0.000 |
Why?
|